We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMO
2751
DELISTED
Capstead Mortgage Corp.
CMO
$9K ﹤0.01%
864
-1,436
-62% -$14.1K
BAS
2752
DELISTED
Basis Energy Services, Inc.
BAS
$9K ﹤0.01%
244
+234
+2,340% +$63.5K
EIO
2753
DELISTED
Eaton Vance Ohio Municipal Bond Fund
EIO
$9K ﹤0.01%
700
-100
-13% -$1.4K
BBOX
2754
DELISTED
Black Box Corp
BBOX
$9K ﹤0.01%
+535
New +$7.67K
CYS
2755
DELISTED
CYS Investments Inc.
CYS
$9K ﹤0.01%
1,144
-1,556
-58% -$12.7K
QUNR
2756
DELISTED
Qunar Cayman Islands Limited
QUNR
$9K ﹤0.01%
+302
New +$8.98K
AC
2757
DELISTED
Associated Capital Group
AC
$8K ﹤0.01%
+267
New +$9.06K
ADVM
2758
DELISTED
Adverum Biotechnologies
ADVM
$8K ﹤0.01%
259
+229
+763% +$7.48K
ANSS
2759
DELISTED
Ansys
ANSS
$8K ﹤0.01%
83
-2,083
-96% -$192K
AR icon
2760
Antero Resources
AR
$10.7B
$8K ﹤0.01%
330
-1,533
-82% -$39.3K
ASTE icon
2761
Astec Industries
ASTE
$1.02B
$8K ﹤0.01%
113
+80
+242% +$5K
ATRA icon
2762
Atara Biotherapeutics
ATRA
$76.1M
$8K ﹤0.01%
+22
New +$9.31K
AVDL
2763
DELISTED
Avadel Pharmaceuticals
AVDL
$8K ﹤0.01%
754
-889
-54% -$9.77K
CAAS icon
2764
China Automotive Systems
CAAS
$133M
$8K ﹤0.01%
+1,466
New +$7.34K
CTSO icon
2765
Cytosorbents Corp
CTSO
$22.6M
$8K ﹤0.01%
1,440
+1,359
+1,678% +$7.44K
EYLD icon
2766
Cambria Emerging Shareholder Yield ETF
EYLD
$874M
$8K ﹤0.01%
+300
New +$7.87K
FCVT icon
2767
First Trust SSI Strategic Convertible Securities ETF
FCVT
$101M
$8K ﹤0.01%
300
-100
-25% -$2.57K
FLO icon
2768
Flowers Foods
FLO
$1.57B
$8K ﹤0.01%
394
-4,726
-92% -$77.8K
FPA icon
2769
First Trust Asia Pacific ex-Japan AlphaDEX Fund
FPA
$109M
$8K ﹤0.01%
300
+69
+30% +$1.96K
FSK icon
2770
FS KKR Capital
FSK
$3.44B
$8K ﹤0.01%
189
-4,709
-96% -$184K
GRFS
2771
Grifois
GRFS
$5.4B
$8K ﹤0.01%
511
-191
-27% -$2.92K
HEES
2772
DELISTED
H&E Equipment Services
HEES
$8K ﹤0.01%
+326
New +$5.97K
HSII
2773
DELISTED
Heidrick & Struggles
HSII
$8K ﹤0.01%
+320
New +$6.74K
IBCP icon
2774
Independent Bank Corp
IBCP
$844M
$8K ﹤0.01%
363
+244
+205% +$4.5K
IBP icon
2775
Installed Building Products
IBP
$6.49B
$8K ﹤0.01%
194
-836
-81% -$31.9K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.